Maryam Peymani
Overview
Explore the profile of Maryam Peymani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
640
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moradi Vastegani Z, Ghaedi-Heidari R, Oroujalian A, Peymani M, Ghaedi K
Metab Brain Dis
. 2025 Mar;
40(3):141.
PMID: 40067516
Parkinson's disease (PD) is a multifaceted neurodegenerative disorder characterized by dopaminergic neuron loss and the presence of Lewy bodies. Beyond its hallmark motor symptoms, PD involves significant neuroinflammation and immune...
2.
Dalali S, Kaviani F, Mahdevar M, Oroujalian A, Peymani M
Genes Genomics
. 2025 Mar;
PMID: 40048143
Background: Colorectal cancer (CRC) is a significant global health issue, with early detection being critical to improving patient survival. Dysregulation of the glycolysis pathway plays a pivotal role in CRC...
3.
Heydari S, Peymani M, Hashemi M, Ghaedi K, Entezari M
Mol Biol Rep
. 2025 Jan;
52(1):151.
PMID: 39847131
Background: The methyltransferase gene family is known for its diverse biological functions and critical role in tumorigenesis. This study aimed to identify these family genes in common gastrointestinal (GI) cancers...
4.
Rezaei Aghdam H, Peymani M, Salehzadeh A, Rouhi L, Zarepour A, Zarrabi A
AAPS J
. 2024 Nov;
27(1):4.
PMID: 39562465
Long non-coding RNAs (lncRNAs) play essential roles as oncogenic factors in cancer progression by influencing cell proliferation, apoptosis, and metastasis pathways. This study aims to investigate the expression changes of...
5.
Dolatabadi B, Peymani M, Rouhi L, Salehzadeh A, Hushmandi K, Hashemi M
Mol Cell Probes
. 2024 Oct;
78:101985.
PMID: 39369912
Introduction: Various pieces of evidence suggest an elevation in the levels of EGFR and HER2 in different cancers leading to the proliferation, invasion, and metastasis of cancer cells. In this...
6.
Morshedzadeh F, Abbaszadegan M, Peymani M, Mozaffari-Jovin S
Funct Integr Genomics
. 2024 Oct;
24(5):183.
PMID: 39367162
In personalized cancer medicine, the identification of KRAS mutations is essential for making treatment decisions and improving patient outcomes. This work presents a comprehensive review of the current approaches for...
7.
Khosroshahi E, Maghsoudloo M, Fahimi H, Mokhtari K, Entezari M, Peymani M, et al.
Heliyon
. 2024 Aug;
10(14):e34464.
PMID: 39114022
Membrane transporters are proteins responsible for facilitating the movement of molecules within biological membranes. They play a vital role in maintaining cellular homeostasis by regulating the transport of nutrients, ions,...
8.
Yavari S, Naseroleslami M, Peymani M, Yekani F, Khayam Nekouei N
Cell J
. 2024 Jul;
26(5):309-319.
PMID: 39066595
Objective: The objective of this study was to assess whether Spen paralogue and orthologue C-terminal domain containing 1 () gene expression could serve as a valuable prognostic and diagnostic biomarker...
9.
Amani M, Peymani M
Mol Biol Rep
. 2024 Jul;
51(1):831.
PMID: 39037563
Background: While many genes linked to colorectal cancer (CRC) contribute to cancer development, a thorough investigation is needed to explore crucial hub genes yet to be fully studied. A pivotal...
10.
Mehdinejad S, Peymani M, Salehzadeh A, Zaefizadeh M
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Jun;
397(11):8771-8783.
PMID: 38837069
This study aimed to address the challenges of treating advanced stages of colon cancer (CRC) by exploring potential therapeutic options. The research focused on the genetic aspects of CRC, specifically...